Nicobrevin's Pedigree

Scientifically-proven to be an effective smoking cessation aid

Nicobrevin was developed by scientists at Germany's Heidelberg University Medical School to assist in alleviating the unpleasant withdrawal symptoms normally experienced when giving up smoking.

Sold for over 40 years
Nicobrevin has been successfully sold by UK chemists for over 40 years and in 11 other countries for lesser periods including New Zealand and Australia.

Scientifically-proven to be an effective smoking cessation aid
The most recent double-blind, placebo-controlled trial to determine the efficacy of Nicobrevin was carried out by Dr Edward Dankwa at the Merian-Iselin Hospital in Basel, Switzerland. The trial (subsequently known as 'The Dankwa Trial') achieved a 62.5% success rate.

The results of this trial were published in the "British Journal of Clinical Practice" and have been accepted as valid proof of efficacy in the countries in which Nicobrevin is sold.

Beware of imitation products!
Due to the worldwide success of Nicobrevin, there are products appearing on the market which have tried to copy Nicobrevin's formula and marketing success but are not registered medicines nor have they been proven by clinical trials.

Cochrane Review
Cochrane Review of Nicobrevin misleading read more